Shanghai Haoyuan Chemexpress Co., Ltd.
public_traded
Shanghai Haoyuan Chemexpress Co., Ltd. is publicly traded on SHH under ticker 688131.SS.
Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.